Recent Updates
Recently added Catalysts
RGEN Positive Sentiment

Repligen Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference

Tuesday, January 7, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Repligen Corporation has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference, scheduled for January 13-16 in San Francisco. The company's CEO, Olivier Loeillot, will deliver a presentation on January 14 at 1:30 p.m. PT, providing an overview of the company. A live webcast of the event will be available via Repligen's Investor Relations website, and a replay will be offered for a limited time post-event.
Price reaction · baseline $154.04 (2025-01-06 close) · hit after-hours · clean, no other RGEN news in the window
day 0 close
-0.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • Repligen Corporation will gain visibility at a significant industry event.
  • Participation in the conference highlights Repligen's leadership in bioprocessing technology.
  • The company's CEO will present, indicating a proactive approach to investor relations.

Full Press Release Details

WALTHAM, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate in the 43rd Annual J.P. Morgan Healthcare Conference, being held January 13 – 16 in San Francisco. Olivier Loeillot, President and Chief Executive Officer, will present an overview of the company on Tuesday, January 14 at 1:30 p.m. PT.
A live webcast of the conference presentation will be accessible through Repligen’s Investor Relations website at www.repligen.com, and will be available for replay for a limited period of time following the event.
About Repligen Corporation

Frequently Asked Questions

When will Repligen present at the J.P. Morgan Healthcare Conference?

Repligen will present on January 14 at 1:30 p.m. PT.

Where can I watch Repligen's conference presentation?

The presentation will be available on Repligen’s Investor Relations website.

What is Repligen Corporation focused on?

Repligen focuses on bioprocessing technology leadership.

When is the J.P. Morgan Healthcare Conference taking place?

The conference runs from January 13 to 16, 2025.

ShareAdd on Google
Tags: RGEN Viatris Investor Conferences Healthcare Repligen Corporation J.P. Morgan Healthcare Conference Olivier Loeillot bioprocessing technology NASDAQ:RGEN
Last updated: Jan 7, 2025

Biotech snapshot

Cash runway
$810M liquidity · $0M/mo burn
Low dilution risk
Lead asset
RG2417Phase 2
Bipolar I Depression →